Degenerative diseases of the brain constitute one of the greatest challenges of the new century for health care in all Western countries.
Degenerative joint disease is a disabling disease that is increasing in its prevalence with the increased life expectancy of Western populations.
Rapid scientific and technological progress often gives rise to serious ethical questions of concern to society.
Health services research is of paramount importance if laboratory based developments are to become realistic treatment options within any healthcare system.
Tissue engineering promises an era of regenerative medicine using products combining manufactured materials with animal or human tissues or cells.
Worldwide over a million patients are newly diagnosed with kidney disease every year.
Sports injuries due to acute trauma require reparative techniques that include tissue engineering.
The ability to manipulate stem cell processes is a necessary requirement for the in vitro generation of tissues by tissue engineering.
Providing the rationale for new biomimetic materials to replace damaged tissue and accelerate wound healing.
Optimal tissue repair and remodelling is the desired goal following any injury to an organ, including the skin.
More than one million people in the UK will undergo tissue repair to the eye at a cost of over £20 million per year to health and social services.